BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

Artiva Biotherapeutics, Inc. – Material Contracts

NASDAQ: ARTV    
Share price (3/24/26): $5.23    
Market cap (3/24/26): $129 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.33
from 10-K 7 pages Artiva Biotherapeutics, Inc. Rsu Award Grant Notice
12/34/56
EX-10.32
from 10-K 9 pages Artiva Biotherapeutics, Inc. Stock Option Grant Notice
12/34/56
EX-10.31
from 10-K 33 pages Artiva Biotherapeutics, Inc. 2025 Inducement Plan Adopted by the Board of Directors: December 9, 2025 1. General
12/34/56
EX-10.30
from 10-K 10 pages February 18, 2026 Thad Huston via Email Private & Confidential Dear Thad,
12/34/56
EX-10.3
from 10-Q 10 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Consulting Agreement
12/34/56
EX-10.2
from 10-Q 13 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.1
from 8-K 27 pages Artiva Biotherapeutics, Inc. 2024 Equity Incentive Plan Adopted by the Board of Directors: July 11, 2024 Approved by the Stockholders: July 11, 2024 Amended by the Board of Directors: April 17, 2025 Approved by the Stockholders: June 24, 2025
12/34/56
EX-10.1
from 10-Q 10 pages March 31, 2025 Subhashis Banerjee Private & Confidential Dear Subhashis,
12/34/56
EX-10.8
from S-1/A 2 pages Artiva Biotherapeutics, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.7
from S-1/A 15 pages Artiva Biotherapeutics, Inc. 2024 Employee Stock Purchase Plan Adopted by the Board of Directors: July 11, 2024 Approved by the Stockholders: July 11, 2024 Ipo Date: [ ], 2024
12/34/56
EX-10.4
from S-1/A 34 pages Artiva Biotherapeutics, Inc. 2024 Equity Incentive Plan Adopted by the Board of Directors: July 11, 2024 Approved by the Stockholders: July 11, 2024
12/34/56
EX-10.38
from S-1 9 pages Consulting Agreement
12/34/56
EX-10.37
from S-1 7 pages Re: Employment Offer Letter Dear Heather, on Behalf of Artiva Biotherapeutics, Inc. (The “Company”), I Am Pleased to Offer You Employment Under the Terms Set Forth in This Offer Letter Agreement (This “Agreement”). These Employment Terms Will Be Effective as of Your Start Date, Which Will Be on or Around October 22, 2020 (The “Start Date”)
12/34/56
EX-10.36
from S-1 8 pages Re: Employment Offer Letter Dear Neha,
12/34/56
EX-10.35
from S-1 3 pages Amendment No. 1 to Consulting Agreement
12/34/56
EX-10.34
from S-1 9 pages Consulting Agreement
12/34/56
EX-10.33
from S-1 12 pages Re: Separation Agreement Dear Pete: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Artiva Biotherapeutics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1. Separation. Your Employment Termination Date Will Be March 31, 2023 (The “Separation Date”)
12/34/56
EX-10.32
from S-1 10 pages 3/28/2023 Michael Faerm Re: Separation Agreement Dear Mike: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Artiva Biotherapeutics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1. Separation. Your Employment Termination Date Will Be March 31, 2023 (The “Separation Date”)
12/34/56
EX-10.31
from S-1 2 pages Amendment No. 1 to Consulting Agreement
12/34/56
EX-10.30
from S-1 9 pages Consulting Agreement
12/34/56